Results 201 to 210 of about 39,580,984 (375)
Can the Binaural System Preserve Temporal Information for Detection of Jitter? [PDF]
Irwin Pollack
openalex +1 more source
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira+14 more
wiley +1 more source
espida Handbook: Expressing project costs and benefits in a systematic way for investment in information and IT [PDF]
Joint Information Systems Comittee+3 more
core
A design for a census information retrieval system [PDF]
Sarah Jane Hobbs+2 more
openalex +1 more source
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian+10 more
wiley +1 more source
Enhancing performance of E-Government information systems with SSD-based Hadoop mapreduce. [PDF]
Ishengoma F.
europepmc +1 more source
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga+8 more
wiley +1 more source
A look at state and local information system efforts [PDF]
Kenneth Dueker
openalex +1 more source
Immunization Information Systems [PDF]
Warren Williams, Laura J. Pabst
openaire +3 more sources
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern+7 more
wiley +1 more source